Alida Biosciences
Pre-clinicalEpiPlex™ assay detects RNA modifications by proximity barcoding and short read RNA sequencing, revealing insights into gene regulation for disease research.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $7.5M
About
EpiPlex™ assay detects RNA modifications by proximity barcoding and short read RNA sequencing, revealing insights into gene regulation for disease research.
Genetics & Genomics
Funding History
1Total raised:$7.5M
Seed$7.5MJun 15, 2022